Search - tctmd.com

Displaying 221 - 240 of 261

Sort: Relevancy | Date

Presentation TCT 2013

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Lisette Okkels Jensen

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Presenter: Piero Montorsi, Antonio Bartorelli, Franco Fabbiocchi, Stefano Galli, Alessandro Lualdi, Paolo Ravagnani, Giovanni Teruzzi, Daniela Trabattoni, Sarah Troiano

January 31, 2013

Presentation TCT 2013

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

Presenter: Sanghoon Shin, Donghoon Choi, Young-Guk Ko

January 31, 2013

$The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...$

Presentation TCT 2013

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Presenter: Tahei Ichinohe, Kazushige Kadota, Haruki Eguchi, Seiji Habara, Hiroyuki Tanaka, Takeshi Tada, Yasushi Fuku, Naoki Oka, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazuaki Mitsudo

January 31, 2013

Presentation TCT 2013

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Presenter: Piotr Buszman, Taylor Palmieri, Maxwell Afari, Armando Tellez, Yanping Cheng, Jong Shiuan Yeh, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Presenter: Francesco Liistro, Paolo Angioli, Guido Bellandi, Leonardo Bolognese, Kenneth Ducci, Italo Porto, Filippo Turini, Giorgio Ventoruzzo

January 31, 2013

Presentation TCT 2013

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Presenter: Maxwell Afari, Armando Tellez, Yanping Cheng, Seung-Jin Oh, Piotr Buszman, Krzysztof Milewski, Jong Shiuan Yeh, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Advertisement

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Paclitaxel-Coated Balloons Show Promise in Two Studies

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Evaluation and Treatment of In-Stent Restenosis

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content